2-(3-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-[1,2,3]triazolo[4,5-c]pyridazin-6-yl)-5-(1,3,4-thiadiazol-2-yl)phenol

ID: ALA4877649

PubChem CID: 156699087

Max Phase: Preclinical

Molecular Formula: C21H24N8OS

Molecular Weight: 436.55

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)CC(n2nnc3cc(-c4ccc(-c5nncs5)cc4O)nnc32)CC(C)(C)N1

Standard InChI:  InChI=1S/C21H24N8OS/c1-20(2)9-13(10-21(3,4)27-20)29-18-16(24-28-29)8-15(23-25-18)14-6-5-12(7-17(14)30)19-26-22-11-31-19/h5-8,11,13,27,30H,9-10H2,1-4H3

Standard InChI Key:  BSCBHDGQVZTZLE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   25.9696   -4.4965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9684   -5.3241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6834   -5.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3999   -5.3236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3971   -4.4929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6816   -4.0837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6759   -3.2613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1152   -5.7350    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6850   -6.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9687   -6.9717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4003   -7.7929    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3973   -6.9698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6885   -8.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9717   -7.7906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3547   -8.3439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.6901   -9.1017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6269   -9.0542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3588  -11.8437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3629  -11.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6462  -11.4275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8299   -9.3474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4214  -10.0642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2464  -10.0595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0675   -9.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8129  -10.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2835  -10.8060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8723   -9.4501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3384   -2.7753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0497   -1.9408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2565   -2.0007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0079   -2.7845    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  4  8  1  0
  9 10  2  0
 10 14  1  0
 13 11  1  0
 11 12  2  0
 12  9  1  0
  3  9  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  1  0
 19 18  1  0
 20 19  1  0
 22 21  1  0
 23 22  1  0
 24 25  1  0
 24 27  1  0
 25 19  1  0
 19 26  1  0
 26 22  1  0
 22 27  1  0
 17 24  1  0
  7 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31  7  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877649

    ---

Associated Targets(Human)

HTT Tchem Huntingtin (19182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.55Molecular Weight (Monoisotopic): 436.1794AlogP: 3.59#Rotatable Bonds: 3
Polar Surface Area: 114.53Molecular Species: BASEHBA: 10HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.83CX Basic pKa: 10.48CX LogP: 1.06CX LogD: 0.54
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -1.02

References

1. Sabnis RW..  (2021)  Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease.,  12  (8.0): [PMID:34413943] [10.1021/acsmedchemlett.1c00356]

Source